Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald is monitoring the performance of Surgery Partners, a healthcare services provider in the US. Raymond James Financial and TD Cowen are also providing price targets and buy ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Surgery Partners
healthcare services company
-
Cantor Fitzgerald
American financial services company
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
TD Cowen
American investment bank
Related events
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald and Wells Fargo raised price targets for Regeneron Pharmaceuticals stock.
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.